Intracellular and Plasma Pharmacokinetics of Saquinavir-Ritonavir, Administered at 1,600/100 Milligrams Once Daily in Human Immunodeficiency Virus-Infected Patients

類似資料

• Pharmacokinetics of Once-Daily Darunavir-Ritonavir and Atazanavir-Ritonavir over 72 Hours following Drug Cessation
  著者:: Boffito, Marta, 等
  出版事項: (2011)
• Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects
  著者:: Boffito, Marta, 等
  出版事項: (2005)
• Pharmacokinetics of Darunavir at 900 Milligrams and Ritonavir at 100 Milligrams Once Daily when Coadministered with Efavirenz at 600 Milligrams Once Daily in Healthy Volunteers
  著者:: Soon, Gaik H., 等
  出版事項: (2010)
• Sequential Population Pharmacokinetic Modeling of Lopinavir and Ritonavir in Healthy Volunteers and Assessment of Different Dosing Strategies
  著者:: Dickinson, Laura, 等
  出版事項: (2011)
• Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals
  著者:: Dickinson, Laura, 等
  出版事項: (2008)